FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

10 results

bromocriptine mesylate
(Bromocriptine mesylate)
Zydus Pharmaceuticals USA Inc.
Usage: Bromocriptine mesylate capsules are indicated for treating hyperprolactinemia-related disorders (e.g., amenorrhea, infertility, hypogonadism), acromegaly, and symptoms of Parkinson's disease. It may be used with levodopa to enhance efficacy and reduce side effects, especially in patients experiencing tolerance or "end of dose failure."
bromocriptine mesylate
(Bromocriptine mesylate)
Sandoz Inc
Usage: Bromocriptine mesylate tablets are indicated for treating hyperprolactinemia-related dysfunctions (e.g., amenorrhea, infertility), acromegaly, and symptoms of Parkinson's disease. They help reduce tumor size in prolactin-secreting adenomas and enhance effects of levodopa in Parkinson's, while potentially reducing levodopa dosage and adverse reactions.
lanreotide acetate
(LANREOTIDE ACETATE)
Cipla USA Inc.
Usage: Lanreotide Injection is indicated for the long-term treatment of acromegaly in patients not responding to surgery/radiotherapy, and for unresectable gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free survival. It also treats adults with carcinoid syndrome, reducing the need for short-acting somatostatin analogs.
octreotide acetate
(octreotide acetate)
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Usage: Octreotide acetate injection is indicated for reducing growth hormone and IGF-1 levels in acromegaly, treating severe diarrhea and flushing from metastatic carcinoid tumors, and managing profuse watery diarrhea from vasoactive intestinal peptide tumors (VIPomas). Clinical trials did not demonstrate improvements in tumor size or growth rate.
octreotide acetate
(octreotide acetate)
Mylan Institutional LLC
Usage: Octreotide acetate injection is used to reduce growth hormone and IGF-1 levels in acromegaly patients who have not responded to other treatments. It also treats severe diarrhea and flushing from metastatic carcinoid tumors and profuse watery diarrhea from vasoactive intestinal peptide tumors (VIPomas).
octreotide acetate
(Octreotide Acetate)
Meitheal Pharmaceuticals, Inc.
Usage: Octreotide Acetate Injection is indicated for managing acromegaly in patients unresponsive to other treatments, treating severe diarrhea and flushing from metastatic carcinoid tumors, and addressing profuse watery diarrhea from vasoactive intestinal peptide tumors (VIPomas). Clinical trials did not confirm its impact on tumor size or growth rate.
r-gene
(Arginine Hydrochloride)
Pharmacia & Upjohn Company LLC
Usage: R-Gene® 10 is indicated as an intravenous stimulant for the release of human growth hormone (HGH) to diagnose pituitary function in conditions like panhypopituitarism, dwarfism, and acromegaly. It aids in confirming HGH reserve deficiencies when previous tests indicate potential issues. Follow-up testing may be required.
sandostatin lar depot
(octreotide acetate)
Novartis Pharmaceuticals Corporation
Usage: SANDOSTATIN LAR DEPOT is indicated for long-term maintenance therapy in acromegaly, and to treat severe diarrhea associated with metastatic carcinoid tumors and VIP-secreting tumors (VIPomas) in patients who have tolerated initial treatment with Sandostatin Injection.
somatuline depot
(lanreotide acetate)
Ipsen Biopharmaceuticals, Inc.
Usage: SOMATULINE DEPOT is indicated for long-term treatment of acromegaly, unresectable gastroenteropancreatic neuroendocrine tumors (GEP-NETs), and carcinoid syndrome in adults. It aims to normalize growth hormone levels, improve progression-free survival in GEP-NETs, and reduce the need for short-acting somatostatin analog rescue therapy in carcinoid syndrome.
somavert
(pegvisomant)
Pharmacia & Upjohn Company LLC
Usage: SOMAVERT is indicated for treating acromegaly in patients with inadequate responses to surgery or radiation, or when these therapies are unsuitable. The aim of treatment is to normalize serum insulin-like growth factor-1 (IGF-1) levels.

Medications for Acromegaly

bromocriptine mesylate

bromocriptine mesylate

lanreotide acetate

octreotide acetate

octreotide acetate

octreotide acetate

r-gene

sandostatin lar depot

somatuline depot

somavert